Rancinamycins 1, II, III and IV are secondary metabolites produced by Streptomyces lincolnensis in a sulfur-depleted culture medium. Rancinamycins I and II, the main components of the mixture, show broad spectrum antibiotic activity in vitro. Subcutaneously injected or orally administered antibiotic afforded no protection for experimentally infected mice against lethal challenges of Staphylococcus aureus. Radioactive tracer studies failed to demonstrate that the rancinamycins were precursors in the biosynthesis of lincomycin.
Subsequently, a number of other lincomycin-related antibiotics were found to be produced by this culto re2,8,4,b)_ All of the antibiotics reported to be produced by S. lincolnensis are produced in either complex or defined media containing inorganic sulfate as the usual source of sulfur. The sulfur of methionine can (also be utilized efficientlye~ .
When S. lincolnensis is grown in a chemically defined medium in the absence of sulfur-containing organic or inorganic compounds a group of new metabolites is produced. The isolation, purification, characterization and biological properties of these compounds, designated rancinamycins I, II, III and IV, are the subjects of the present communication.
Experimental
Spectroscopic Procedures PMR spectra were recorded on a Varian A-60 spectrometer. All preparations were run in either D2O or d6-dimethylsulfoxide (de-DMSO) using sodium 2,2-dimethyl-2-silapentane-5-sulfonate (SDSS) or tetra methylsilane (TMS) as internal reference.
Gas Chromatography-Mass Spectroscopy (GC-MS) Gas-Chromatographic separation was done on a GC Varian Aerograph series 2700 chromatograph using a 6 ft., 3.8% UCW-98 on 80100 mesh Diatoport-S column (Hewlett-Packard).
The operation was performed isothermally at 185°C. The mass spectra were recorded on a CH7 Massenspectrometer (Varian Mat., West Germany) operating at 70 electron volts.
It was found necessary to prepare the trimethylsilyl ethers of rancinamycins in order to obtain volatile compounds satisfactory for gas chromatographic analysis. This was done by reacting 50 ,ul of a 1 mg/ml solution of a rancinamycin preparation in dimethylformamide with 50 ,ul of Regisil® (Regis Chemical Co.). The reaction mixture was allowed to stand at room temperature for 30 minutes. Assay Procedures Antibiotic production was measured by a microbiological disc-plate assay procedure') using Proteus vulgaris (UC-93), Proteus rettgeri (UC-344), Staphylococcus aureus (UC-80), and Sarcina lutea (UC-130) as the assay organisms.
Paper and Thin-layer Chromatographic Procedures Fermentation, purification and separation studies were followed by paper chromatography using water-saturated 1-butanol as the solvent system.
Thin-layer chromatograms were run on Analtech silica gel GF plates (Analtech Inc.) using ethyl acetate saturated with water (system I), methyl ethyl ketone -acetone -water (186: 52:10, v/v) (system II) or methyl ethyl ketone -acetone -water (186: 52: 22, v/v) (system III) as the solvent systems.
The antibiotics, separated either by paper or tic chromatography, were detected by bioautography on P. vulgaris-seeded agar trays.
Fermentation Procedures
Seed cultures of S. lincolnensis were prepared in a medium consisting of glucose monohydrate, 25 g/liter and Pharmamedia, 25 g/liter (Trader's Oil Mill Co., Forth Worth, Texas, USA); seed presterilization pH 7.2. The cultures were incubated at 28°C for 72 hours on a rotary shaker (250 rpm). A fermentation medium consisting of anhydrous glucose , 30 g/liter; sodium citrate, 1.8 g/liter; dipotassium phosphate, 2.5 g/liter; sodium chloride 0.5 g/liter; ammonium nitrate, 2.0 g/liter; zinc chloride 0.47 mg/ liter; ferrous chloride tetrahydrate 0.72 mg/liter; magnesium citrate , 1.2 g/liter and lard oil 10 ml/liter was adjusted to pH 7.2 and inoculated at a rate of 5 % (v/v) with the 72-hour seed culture. Fermentations were incubated at 28°C on a rotary shaker and beers were harvested after total fermentation time of 7296 hours.
Isolation Procedures
Adsorption on Amberlite XAD-4: The whole beer (10 liters) was filtered using diatomaceous earth (Dicalite, 4200, Grefco Inc.). Part of the clear beer (1.5 liters) was passed through a column prepared from 100 ml of Amberlite XAD-4* (Rohm and Haas Co.). The spent, collected in one fraction, was bioinactive and was discarded. The column was then washed with 500 ml of water; the aqueous wash was also bioinactive and was discarded. The column was eluted with methanol-water (95: 5, v/v). Fractions containing rancinamycins were concentrated to an aqueous solution and freezedried to yield 2.55 g of crude rancinamycin preparation.
Adsorption on Granulated Activated Carbon: Another portion (1.5 liters) of the clear beer, obtained as described above, was passed through a column containing 80 g of Cal Carbon (Pittsburgh Activated Carbon). The column was washed with750 ml of water; both spent and the aqueous wash were found bioinactive and were discarded. The column was successively eluted with 750 ml of acetone -water (20: 80, v/v), 250 ml of acetone -water (40: 60, v/v) and acetone -water (90: 10, v/v). Fractions collected with acetone-water (90: 10, v/v), containing rancinamycins, were combined, concentrated to an aqueous solution and freeze-dried to yield 1.22 g of crude rancinamycins.
Purification Procedures Separation of Rancinamycins by Countercurrent Distribution:
Three grams of crude rancinamycins, obtained by the carbon adsorption method, was distributed in an all glass countercurrent distribution apparatus (500 tubes, 10 ml/phase) using a solvent system consisting of equal volumes of 1-butanol and water. A total of 467 transfers were completed. The distribution was followed by determination of solids and bioactivity. Results which7are presented in Fig. 2 showed the presence of four active components with K values of 0.52, 1.15, 2.40 and 5.95. Tubes under the peak with a K value of 1.15 were found to contain rancinamycin I, while rancinamycin II was found in the fractions under the peak with a K value of 2.40. Concentration of appropriate fractions yielded rancinamycins * Amberlite XAD -4 was successively washed with the following before use: 2 bed volumes of 50: 50 acetonewater, 2 bed volumes of acetone, 2 bed volumes of methanol, 2 bed volumes of 50:50 methanol -water, and 20 bed volumes of water.
I and II isolated as viscous oils which crystallized (colorless needles) on standing. The small amounts of the bioactive components with K values of 0.52 (rancinamycin III) and 5.95 (rancinamycin IV) were not isolated by this procedure but by the purification sequence described below.
Separation of Rancinamycins by Amberlite XAD-4 Chromatography, Silica Gel Chromatography and Countercurrent Distribution:
Ninety grams of crude rancinamycins obtained from a large scale fermentation (by the carbon process) were dissolved in one liter of water (resulting pH was 4.5). This solution was passed over a 2-liter Amberlite XAD-4 column. The spent, collected as one fraction, was bioinactive and was discarded. The column was then washed with water (6 liters) collected as one fraction. The aqueous wash was also bioinactive and was discarded. The column was eluted with methanol-water (50: 50, v/v). Fractions containing rancinamycins were combined, concentrated to an aqueous solution and freeze-dried to give 56 g of material containing all rancinamycins.
Twenty-one grams of this crude rancinamycin was dissolved in 50 ml of water. The solution was mixed with 100 g of silica gel (Merck-Darmstadt, Art 7704). This mixture was dried in vacuo and added on the top of a glass column (7 cm internal diameter) containing 1.8 kg of silica gel packed in a solvent consisting of methyl ethyl ketone -acetone -water (186: 52: 3, v/v). Bioactive fractions obtained by elution of the column with the solvent system were combined and concentrated to dryness in vacuo to give 7.9 g of slightly colored viscous material containing rancinamycins I to IV.
The purified rancinamycin mixture, obtained as described above, was dissolved in 50 ml of each phase of the solvent system consisting of equal volumes of 1-butanol -water. The solutions were added in the first five tubes of an all-glass countercurrent distribution apparatus (500 tubes, 10 ml/phase). After 500 transfers the distribution was analyzed by thin-layer chromatography using systems I and II and by bioassays. Rancinamycins I, 0.64 g; 11, 0.58 g; III, 0.29 g; and IV, 1.79 g were isolated by concentration of the appropriate fractions. Characterization of these materials is described in Discussion and Results.
Rancinamycin I-2,4-Dinitrophenylhydrazone
One hundred sixty mg of rancinamycin I was dissolved in 10 ml of water. This solution was mixed with 420 ml of a solution prepared by dissolving I g of 2,4-dinitrophenylhydrazine in 1 liter of 2 N aqueous hydrochloric acid. The mixture was allowed to stand at room temperature for 24 hours. The crystalline precipitate formed, was separated by filtration and dried, 130 mg.
Anal Crude rancinamycin, obtained by the carbon adsorption process described earlier, was dissolved in 50 ml of water. This solution was mixed with 2 liters of a solution prepared by dissolving 1 g of 2,4-dinitrophenylhydrazone in I liter of 2 N aqueous hydrochloric acid. Formation of an orange precipitate started immediately. The mixture was allowed to stand at room temperature for 24 hours. The precipitated mixture of the 2,4-dinitrophenylhydrazones of rancinamycins I and II was separated by filtration and dried (2.28 g).
Separation of 2,4-Dinitrophenylhydrazones of Rancinamycins I and d II. Countercurrent Distribution.
The mixture of 2,4-dinitrophenylhydrazones of rancinamycins I and II was distributed in an allglass CRAIG countercurrent distribution apparatus (500 tubes, 10 ml/phase) using a solvent system consisting of equal volumes of cyclohexane, ethyl acetate, 95 % ethanol and water. After 465 transfers the distribution was analyzed by solid determination. Tubes 180230, containing rancinamycin 1-2,4-THE JOURNAL OF ANTIBIOTICS AUG. 1976 dinitrophenylhydrazone, were concentrated to dryness to give 790 mg of crystalline material. Similarly, tubes 243280 gave 400 mg of crystalline rancinamycin II-2,4-dinitrophenylhydrazone.
Preparation of Radioactive Rancinamycins
The fermentation conditions were identical to those described earlier. Uniformly labeled 14C_ glucose was used as the radioactive precursor. Approximately one per cent of the radioactivity added was incorporated into the crude rancinamycins isolated by the carbon adsorption process discussed earlier. This radioactive rancinamycin mixture (specific activity of 6 x 104 cpm/mg) was added to a lincomycin-producing fermentation of S. lincolnensis as described below.
Addition of !4C-Rancinamycins to Fermentation of S. lincolnensis Producing Lincomycin The fermentation conditions were identical to those described by ARGOUDELis et ale). Radioactive 14C-rancinamycin obtained as described above was added to the fermentation medium 48 hours after inoculation. The fermentation was followed by bioactivity determinations using both P. vulgaris (specific for rancinamycins) and S. lutea (specific for lincomycin) as the assay organisms. Results are discussed in the Results and Discussion section. (Fig. 3 ). However gas chromatographymass spectroscopy (see below) indicated that each of rancinamycins I, II and III was a mixture of isomeric compounds which could not be separated by either CCD or the chromatographic techniques (paper or tic) used. Rancinamycin IV on the other hand, isolated as colorless crystalline (needles) solid, was found to contain one material only. By mass spectrometry and data of its 2,4-dinitrophenylderivative (see Table 2 ). d TMS=trimethylsilyl .
Rancinamycins-2,4-Dinitrophenylhydrazone (-2,4-DNPH)
Rancinamycins I, II and III are hygroscopic materials which do not give satisfactory analytical data .
Therefore, use was made of the property of all rancinamycins to give crystalline 2,4-dinitrophenylhydrazone derivatives which could be purified and characterized. Two procedures were used for the preparation of these derivatives. In the first method rancinamycins I, II, III and IV were separated by CCD (as described earlier) and the individual rancinamycins were reacted with solution of 2,4-dinitrophenylhydrazine in aqueous hydrochloric acid. In the second procedure crude rancinamycin was transformed to the mixture of rancinamycins-2,4-DNPH. Rancinamycins I and II-2,4-DNPH were then separated by CCD using cyclohexane -ethyl acetate -95 % ethanol -water (1: 1: 1: 1, v/v). The dinitrophenylhydrazones obtained by either method had identical properties and like the rancinamycins were mixtures of isomeric compounds. Offset 225 Cps
Offset 220 cps Table 3 . Gas chromatographic-mass spectroscopic analysis*. Similarly, rancinamycin II was found to be a mixture of five components (rancinamycins IIa, IIb, IIc, lid and IIe) ( Table 3 ). All components had identical molecular weight (474) and identical fragmentation patterns in the mass spectra of their TMS-derivativese), indicative of the isomeric character of the rancinamycin II components. The formation of tri-TMS derivatives indicates that rancinamycins II also contains three hydroxyl groups.
Rancinamycin IIa and lie are the main components comprising ca. 86 % of rancinamycin II. The characterization data recorded on Tables 1 and 2 for rancinamycins I, II and their 2,4-dinitrophenylhydrazones, with the exception of the specific rotations and the melting points, are not effected by the finding that each antibiotic is a mixture of isomeric components.
Since small amounts of rancinamycin III were isolated, this material was not completely char- Table 3 ). The molecular weight (462) and fragmentation pattern of the TMS-derivatives of these components was identical. The formation of tetra-TMS derivative shows the presence of four hydroxyl groups. Rancinamycin III forms a 2,4-dinitrophenylhydrazone which exhibits UV spectrum identical to that of rancinamycins I and II (Table 2) indicating the presence of the same chromophoric system in rancinamycins I, II and III.
Rancinamycin IV, C7H008 (molecular weight: found 138.0307; calcd. 138.0317) was isolated as colorless crystalline material. Gas chromatographic mass spectroscopic analysis of the trimethylsilyl derivative of rancinamycin IV indicated the presence of one component with retention time of 4.5 minutes. IR and PMR spectra indicated that rancinamycin IV is 3,4-dihydroxybenzaldehyde8).
Biological Properties of Rancinamycins
The antibacterial spectrum of rancinamycins I, II, III and IV is presented in Table 4 . The antibacterial activity of rancinamycins I, TI and III is destroyed by cysteine, by reagents reacting with carbonyl groups such as hydrogen sulfite and by reduction with sodium borohydride. In addition, the antibiotics were unstable in acidic or basic solutions. Rancinamycins I and II were inactive both orally and subcutaneously against Staphylococcus aureus infected mice.
Rancinamycins as Precursors in Lincomycin Biosynthesis
The possibility that rancinamycins might be intermediates in the biosynthesis of lincomycin was suggested by the finding that these compounds are related to shikimic acid8) and that aromatic acids (phenylalanine, tyrosine) are involved in the biosynthesis of the amino acid moiety of lincomycin0). To test this hypothesis uniformly labeled 14C-rancinamycin complex was prepared by the use of uniformly labeled 14C-glucose. About 1.0% of the radioactivity added to the fermentation medium was incorporated into rancinamycins. The radioactive rancinamycin complex was then added into a lincomycin producing fermentation.
As shown in Table 6 the rancinamycin bioactivity (P. vulgaris) was rapidly lost. The radioactivity level in the fermentation supernatant liquid, however, remained constant throughout the fermentation. Lincomycin, isolated as the crystalline hydrochloride, was radioinactive indicating that rancinamycins were not utilized for biosynthesis of lincomycin under the conditions used. The rapid loss of P. vulgaris activity was due, probably, to the instability of the rancinamycins to the acidic conditions early in the fermentation.
